108 related articles for article (PubMed ID: 30312658)
1. Loss of hypermethylated in cancer 1 (HIC1) promotes lung cancer progression.
Li Y; Yao M; Wu T; Zhang L; Wang Y; Chen L; Fu G; Weng X; Wang J
Cell Signal; 2019 Jan; 53():162-169. PubMed ID: 30312658
[TBL] [Abstract][Full Text] [Related]
2. Hypermethylated in cancer 1(HIC1) suppresses non-small cell lung cancer progression by targeting interleukin-6/Stat3 pathway.
Wang X; Wang Y; Xiao G; Wang J; Zu L; Hao M; Sun X; Fu Y; Hu G; Wang J
Oncotarget; 2016 May; 7(21):30350-64. PubMed ID: 27107418
[TBL] [Abstract][Full Text] [Related]
3. HIC1 modulates prostate cancer progression by epigenetic modification.
Zheng J; Wang J; Sun X; Hao M; Ding T; Xiong D; Wang X; Zhu Y; Xiao G; Cheng G; Zhao M; Zhang J; Wang J
Clin Cancer Res; 2013 Mar; 19(6):1400-10. PubMed ID: 23340301
[TBL] [Abstract][Full Text] [Related]
4. Epigenetic silencing of HIC1 promotes epithelial-mesenchymal transition and drives progression in esophageal squamous cell carcinoma.
Li P; Liu X; Dong ZM; Ling ZQ
Oncotarget; 2015 Nov; 6(35):38151-65. PubMed ID: 26510908
[TBL] [Abstract][Full Text] [Related]
5. The tumor suppressor gene hypermethylated in cancer 1 is transcriptionally regulated by E2F1.
Jenal M; Trinh E; Britschgi C; Britschgi A; Roh V; Vorburger SA; Tobler A; Leprince D; Fey MF; Helin K; Tschan MP
Mol Cancer Res; 2009 Jun; 7(6):916-22. PubMed ID: 19491197
[TBL] [Abstract][Full Text] [Related]
6. The tumor suppressor Hic1 maintains chromosomal stability independent of Tp53.
Szczepny A; Carey K; McKenzie L; Jayasekara WSN; Rossello F; Gonzalez-Rajal A; McCaw AS; Popovski D; Wang D; Sadler AJ; Mahar A; Russell PA; Wright G; McCloy RA; Garama DJ; Gough DJ; Baylin SB; Burgess A; Cain JE; Watkins DN
Oncogene; 2018 Apr; 37(14):1939-1948. PubMed ID: 29367758
[TBL] [Abstract][Full Text] [Related]
7. HIC1 loss promotes prostate cancer metastasis by triggering epithelial-mesenchymal transition.
Hao M; Li Y; Wang J; Qin J; Wang Y; Ding Y; Jiang M; Sun X; Zu L; Chang K; Lin G; Du J; Korinek V; Ye DW; Wang J
J Pathol; 2017 Aug; 242(4):409-420. PubMed ID: 28466555
[TBL] [Abstract][Full Text] [Related]
8. HIC1 Tumor Suppressor Loss Potentiates TLR2/NF-κB Signaling and Promotes Tissue Damage-Associated Tumorigenesis.
Janeckova L; Pospichalova V; Fafilek B; Vojtechova M; Tureckova J; Dobes J; Dubuissez M; Leprince D; Baloghova N; Horazna M; Hlavata A; Stancikova J; Sloncova E; Galuskova K; Strnad H; Korinek V
Mol Cancer Res; 2015 Jul; 13(7):1139-48. PubMed ID: 25934696
[TBL] [Abstract][Full Text] [Related]
9. Inactivation of tumor suppressor gene HIC1 in gastric cancer is reversed via small activating RNAs.
Pan S; Wang Z; Chen Y; Chen X; Ji J; Zhang J; Li J; Cai Q; Liu B; Zhu Z; Yu Y
Gene; 2013 Sep; 527(1):102-8. PubMed ID: 23769968
[TBL] [Abstract][Full Text] [Related]
10. HIC1 modulates uveal melanoma progression by activating lncRNA-numb.
Cheng G; He J; Zhang L; Ge S; Zhang H; Fan X
Tumour Biol; 2016 Sep; 37(9):12779-12789. PubMed ID: 27449031
[TBL] [Abstract][Full Text] [Related]
11. The receptor tyrosine kinase EphA2 is a direct target gene of hypermethylated in cancer 1 (HIC1).
Foveau B; Boulay G; Pinte S; Van Rechem C; Rood BR; Leprince D
J Biol Chem; 2012 Feb; 287(8):5366-78. PubMed ID: 22184117
[TBL] [Abstract][Full Text] [Related]
12. HIC1 attenuates invasion and metastasis by inhibiting the IL-6/STAT3 signalling pathway in human pancreatic cancer.
Hu B; Zhang K; Li S; Li H; Yan Z; Huang L; Wu J; Han X; Jiang W; Mulatibieke T; Zheng L; Wan R; Wang X; Hu G
Cancer Lett; 2016 Jul; 376(2):387-98. PubMed ID: 27085461
[TBL] [Abstract][Full Text] [Related]
13. The Reelin receptors ApoER2 and VLDLR are direct target genes of HIC1 (Hypermethylated In Cancer 1).
Dubuissez M; Faiderbe P; Pinte S; Dehennaut V; Rood BR; Leprince D
Biochem Biophys Res Commun; 2013 Oct; 440(3):424-30. PubMed ID: 24076391
[TBL] [Abstract][Full Text] [Related]
14. Hypermethylation of the HIC1 promoter and aberrant expression of HIC1/SIRT1 contribute to the development of thyroid papillary carcinoma.
Wu W; Zhang L; Lin J; Huang H; Shi B; Lin X; Huang Z; Wang C; Qiu J; Wei X
Oncotarget; 2016 Dec; 7(51):84416-84427. PubMed ID: 27793057
[TBL] [Abstract][Full Text] [Related]
15. Hypermethylation of HIC1 promoter and aberrant expression of HIC1/SIRT1 might contribute to the carcinogenesis of pancreatic cancer.
Zhao G; Qin Q; Zhang J; Liu Y; Deng S; Liu L; Wang B; Tian K; Wang C
Ann Surg Oncol; 2013 Dec; 20 Suppl 3():S301-11. PubMed ID: 22552606
[TBL] [Abstract][Full Text] [Related]
16. Inactivation of the hypermethylated in cancer 1 tumour suppressor--not just a question of promoter hypermethylation?
Jenal M; Britschgi C; Fey MF; Tschan MP
Swiss Med Wkly; 2010; 140():w13106. PubMed ID: 21104471
[TBL] [Abstract][Full Text] [Related]
17. HIC1 silencing in triple-negative breast cancer drives progression through misregulation of LCN2.
Cheng G; Sun X; Wang J; Xiao G; Wang X; Fan X; Zu L; Hao M; Qu Q; Mao Y; Xue Y; Wang J
Cancer Res; 2014 Feb; 74(3):862-72. PubMed ID: 24295734
[TBL] [Abstract][Full Text] [Related]
18. DNA double-strand breaks lead to activation of hypermethylated in cancer 1 (HIC1) by SUMOylation to regulate DNA repair.
Dehennaut V; Loison I; Dubuissez M; Nassour J; Abbadie C; Leprince D
J Biol Chem; 2013 Apr; 288(15):10254-64. PubMed ID: 23417673
[TBL] [Abstract][Full Text] [Related]
19. The promoter methylation drives down-regulation mode of HIC1 in gastric cancer, its molecular characteristics and downstream functional pathways.
Zhao T; Yang T; Zhang J; Hao H; Wang D; Afirifa J; Cai M; Cui X; Bai J; Fu S; Yu J
Gene; 2022 May; 824():146380. PubMed ID: 35276239
[TBL] [Abstract][Full Text] [Related]
20. HIC1 (hypermethylated in cancer 1) SUMOylation is dispensable for DNA repair but is essential for the apoptotic DNA damage response (DDR) to irreparable DNA double-strand breaks (DSBs).
Paget S; Dubuissez M; Dehennaut V; Nassour J; Harmon BT; Spruyt N; Loison I; Abbadie C; Rood BR; Leprince D
Oncotarget; 2017 Jan; 8(2):2916-2935. PubMed ID: 27935866
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
